Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Traditional Chinese Medicine for Alzheimer’s Disease and Other Cognitive Impairment: A Review
Hui Pei, Lina Ma, Yu Cao, et al.
The American Journal of Chinese Medicine (2020) Vol. 48, Iss. 03, pp. 487-511
Closed Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Pathogenesis of depression and the potential for traditional Chinese medicine treatment
Weixing Ding, Lulu Wang, Lie Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 33
Traditional Chinese medicine for dementia
Song Li, Zhengzhi Wu, Weidong Le
Alzheimer s & Dementia (2021) Vol. 17, Iss. 6, pp. 1066-1071
Closed Access | Times Cited: 75
Transcranial Direct Current Stimulation Enhances Cognitive Function in Patients with Mild Cognitive Impairment and Early/Mid Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Jiajie Chen, Zheng Wang, Qin Chen, et al.
Brain Sciences (2022) Vol. 12, Iss. 5, pp. 562-562
Open Access | Times Cited: 45
Astragalus species: Phytochemistry, biological actions and molecular mechanisms underlying their potential neuroprotective effects on neurological diseases
Heba‐Tallah Abd Elrahim Abd Elkader, Amina E. Essawy, Ahmed S. Al‐Shami
Phytochemistry (2022) Vol. 202, pp. 113293-113293
Closed Access | Times Cited: 42
Kaempferol as a therapeutic agent in Alzheimer’s disease: Evidence from preclinical studies
Xiaoyu Dong, Siyu Zhou, Jianfei Nao
Ageing Research Reviews (2023) Vol. 87, pp. 101910-101910
Closed Access | Times Cited: 38
Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases
Ying‐Hao Han, Xiaodong Liu, Meihua Jin, et al.
Inflammation Research (2023) Vol. 72, Iss. 9, pp. 1839-1859
Closed Access | Times Cited: 30
Brain organoids are new tool for drug screening of neurological diseases
Chong Gao, Jin-Qi Zhou, Linghui Zeng, et al.
Neural Regeneration Research (2023)
Open Access | Times Cited: 29
Levistilide A ameliorates neuroinflammation via inhibiting JAK2/STAT3 signaling for neuroprotection and cognitive improvement in scopolamine-induced Alzheimer’s disease mouse model
H. Ni, Yanfang Liao, Yifan Zhang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110783-110783
Closed Access | Times Cited: 26
Ginsenoside RK1 improves cognitive impairments and pathological changes in Alzheimer's disease via stimulation of the AMPK/Nrf2 signaling pathway
Lingyu She, Jinfeng Sun, Xiong Li, et al.
Phytomedicine (2023) Vol. 122, pp. 155168-155168
Open Access | Times Cited: 24
Chicoric Acid Ameliorated Beta-Amyloid Pathology and Enhanced Expression of Synaptic-Function-Related Markers via L1CAM in Alzheimer’s Disease Models
Ruonan Wang, Shijia Kang, Zirui Zhao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3408-3408
Open Access | Times Cited: 8
Pharmaceutical Humanities and Narrative Pharmacy: An Emerging New Concept in Pharmacy
Mita Banerjee, Thomas Efferth
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 48-48
Open Access | Times Cited: 1
Effects of Tai Chi and Qigong on cognitive and physical functions in older adults: systematic review, meta-analysis, and meta-regression of randomized clinical trials
Moonkyoung Park, Rhayun Song, Kyoungok Ju, et al.
BMC Geriatrics (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
Jinfan Li, Dong Li, Yajie Chen, et al.
Clinical Interventions in Aging (2023) Vol. Volume 18, pp. 963-986
Open Access | Times Cited: 18
Constituents, pharmacological activities, pharmacokinetic studies, clinical applications, and safety profile on the classical prescription Kaixinsan
Liping Chen, Lin Jiang, Xiaoyu Shi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR‐124 and miR‐155 in Experimental Autoimmune Encephalomyelitis
Zheng Zha, Yan-Fang Gao, Jing Ji, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 33
Higher Total Cholesterol Concentration May Be Associated with Better Cognitive Performance among Elderly Females
Ke Pang, Chunxia Liu, Jianbin Tong, et al.
Nutrients (2022) Vol. 14, Iss. 19, pp. 4198-4198
Open Access | Times Cited: 25
Nao Tan Qing ameliorates Alzheimer's disease-like pathology by regulating glycolipid metabolism and neuroinflammation: A network pharmacology analysis and biological validation
Qianqian Li, Caixia Jia, Hongxing Wu, et al.
Pharmacological Research (2022) Vol. 185, pp. 106489-106489
Closed Access | Times Cited: 23
Betaine Mitigates Amyloid-β-Associated Neuroinflammation by Suppressing the NLRP3 and NF-κB Signaling Pathways in Microglial Cells
Yue Zhang, Jianping Jia
Journal of Alzheimer s Disease (2023) Vol. 94, Iss. s1, pp. S9-S19
Open Access | Times Cited: 13
Traditional Chinese medicine for the treatment of Alzheimer's disease: A focus on the microbiota–gut–brain axis
Lina Ma, Xuefan Jiang, Qiao-yi Huang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115244-115244
Open Access | Times Cited: 13
Elucidating the Mechanisms of Shenwu Capsule in Improving the Cognitive Decline in Aging based on the UPLC-Q-TOF-MS, Network Pharmacology, and Experimental Validation
Zizhao Cheng, Shengyao Wang, Xuesi Hua, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116818-116818
Open Access
Traditional Chinese medicine as a viable option for managing vascular cognitive impairment: A ray of hope
Di Liu, Yue Zhao, RunFeng Liu, et al.
Medicine (2025) Vol. 104, Iss. 11, pp. e41694-e41694
Open Access
Icariin ameliorate Alzheimer’s disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis
Yao Chen Chuang, Iat‐Kio Van, Yonghua Zhao, et al.
Journal of Chemical Neuroanatomy (2021) Vol. 117, pp. 102014-102014
Closed Access | Times Cited: 28
Medicine-Food Herbs against Alzheimer’s Disease: A Review of Their Traditional Functional Features, Substance Basis, Clinical Practices and Mechanisms of Action
Pengfei Guo, Baoyue Zhang, Jun Zhao, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 901-901
Open Access | Times Cited: 19
Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway
Wei Wei, Jiuxiu Yao, Tingting Zhang, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 12
Astragaloside IV attenuates neuroinflammation and ameliorates cognitive impairment in Alzheimer’s disease via inhibiting NF-κB signaling pathway
He Li, Jinxia Sun, Zhulei Miao, et al.
Heliyon (2023) Vol. 9, Iss. 2, pp. e13411-e13411
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top